You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Hot spot scanning | the concept of pharmaceutical outsourcing is on the rise, while Tiger Pharmaceuticals is up nearly 6%.

USMART Yingli Zhi Investment reported that as of press time, the three major indexes of Hong Kong stocks rose, the Hang Seng index rose 1.93% to 20514.5 points, with a turnover of 53.287 billion; the state-owned enterprises index rose 2.1% to 7043.64 points, with a turnover of 19.411 billion; and the red chip index rose 1.3% to 3886.03 points with a turnover of 2.064 billion.

The online education sector was among the top gainers, with New Oriental up more than 13%, thinking Music Education up more than 6%, New Oriental online up 3.55%, and Zhuoyue Education Group up more than 1%.

Coal stocks rose sharply, Yanzhou Mining Energy rose more than 6%, Shougang Resources rose more than 5%, China Coal Energy, China Shenhua, Yitai Coal all rose more than 4%, Mongolia Coking Coal and Yunnan Coal rose in Australia.

The concept of pharmaceutical outsourcing is up, Tiger Pharmaceuticals is up nearly 6%, Pharmaceutical Bio is up more than 4%, Vivia Biology and Kanglong Chemical are up more than 3%, Zhaoyan Xinyao, Kellein and Yao Ming Kant are up.

Automobile stocks diverged. Weilai rose more than 8%, Xiaopeng Motor rose 6.55%, ideal car rose more than 4%, BYD shares and Wuling Motor rose more than 2%, Great Wall Motor fell 1.62%, GAC GROUP and Dongfeng Group followed suit.

Hot stocks

Wanguo data rose higher and is now up 9.27% to HK $30.05, with a total market capitalization of HK $46 billion. The company announced last night that net income in the first quarter was 2.2436 billion yuan ($353.9 million), up 31.5% from a year earlier, adjusted EBITDA was 1.0512 billion yuan ($165.8 million), up 28.5% from a year earlier, and adjusted EBITDA profit margin was 46.9%.

Under the continuing influence of the epidemic, Wanguo data ensured a stable performance in the first quarter with strong business flexibility and risk resistance. It is reported that since the launch of the "calculation of the East and the West" project, Wanguo data has continuously improved its layout in the eastern and western frontlines of the country and the surrounding cities, promoting the orderly and coordinated development of eastern and western computing power.

Hong Kong shares 600690.SH rose 5.2 per cent to HK $27.3 in intraday trading, while A shares Haier Zhijia rose 2.81 per cent to 26 yuan, with a total market capitalization of 245.6 billion yuan. Haier Zhijia announced that it will spend 82.929 million yuan on May 19, 2022 to buy back 3.2867 million A shares at a repurchase price of 25-25.4 yuan per share.

Kangxinuo biological rose more than 9% to HK $77.5. Kangchino announced that the World Health Organization disclosed on its website on May 19 that the company's recombinant novel coronavirus vaccine (adenovirus type 5) Kweissa ®had been added to the "Emergency use list" ("EUL"). After the product is included in the WHOEUL, the company still needs to conduct commercial negotiations with the intended countries on the future sales of the product. If the overseas countries increase the procurement and use of the product, it will have a positive impact on the performance of listed companies.

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account